Latest Medication News

  • For more information on all medications available in UMMC, please click here.
  • For procedures on how to request to include medication into UMMC's Formulary, please click here.
  • All displayed images are for illustration purpose only.

Medication Supply Resumes

posted Aug 15, 2018, 6:03 PM by Chong Ching Wern   [ updated Aug 15, 2018, 6:07 PM ]

15 August 2018 (Circular No. SP PPUM: 325/2018):
We are pleased to inform that our Pharmacy Department have received stocks for the following medications: 

No.

Name of Medication

Formulary Category


1)

Fentanyl 100mcg/2mL Injection


Standard Formulary

2)

Thiopental 500mg Injection



Standard Formulary

Discontinued Medication - Pilocarpine 2% and 4% Eye Drop

posted Jul 22, 2018, 9:18 PM by Chong Ching Wern   [ updated Jul 22, 2018, 9:19 PM ]

20 July 2018 (Circular No. SP PPUM: 283/2018):
Name of Medication: Pilocarpine 2% and 4%
Form: Eye Drop
Company: Alcon Laboratories (M) Sdn. Bhd.
Formulary Category: Standard

The sole distributor of Pilocarpine both 2% and 4% eye drops, Alcon Laboratories (M) Sdn. Bhd., had ceased their production and our pharmacy will supply our patients until all our current stocks have been used up.

However, doctors can consider to use other Standard Formulary eye drops such as Latanoprost and Timolol as an alternative for our patients.

Medication Supply Disruption

posted Jul 12, 2018, 6:35 PM by Chong Ching Wern   [ updated Jul 12, 2018, 6:43 PM ]

13 July 2018 (Circular No. SP PPUM: 270/2018):
The following medication will be facing supply disruptions:

No.

Name of Medication

Formulary Category

Cause / Action by Pharmacy

Estimated Stock Recovery

Alternative Medication


1)

Thiopental 500mg Injection

Standard Formulary

· Production issues by Pharmaforte (Malaysia) Sdn. Bhd.

· All stocks that the Pharmacy have were expired and have been returned for replacement. 

August 2018.

Consider use of Propofol Injection

Medication Supply Resumes

posted Jul 3, 2018, 7:54 PM by Chong Ching Wern   [ updated Aug 15, 2018, 6:07 PM ]

3 July 2018 (Circular No. SP PPUM: 241/2018):
We are pleased to inform that the following medications will have their supplies back to normal: 

No.

Name of Medication

Formulary Category


1)

Albumin Human 20% Injection


Standard Formulary

2)

Prothrombin Complex (Factor II, VII, IX, X) Injection (Octaplex)



Standard Formulary

New Medication - Darbepoetin Alfa 40mcg/0.5mL Injection

posted Jul 3, 2018, 7:16 PM by Chong Ching Wern   [ updated Jul 3, 2018, 7:18 PM ]

3 July 2018 (Circular No. SP PPUM: 240/2018):
Name of Medication: Darbepoetin Alfa
Brand: NESP
Form: Injection
Manufacturer: Kyowa Hakko Kirin Co., Ltd
Formulary Category: Standard
Prescriber: Nephrologist
Restrictions: For anaemia associated with chronic kidney failure.

Based on the outcome of the Drug and Therapeutics Subcommittee Meeting (Bil. 02/2015), Darbepoetin Alfa 40mcg/0.5mL Injection will be replacing Epoetin Beta 5000iu Injection (Recormon 5000).
Darbepoetin Alfa 40mcg/0.5mL Injection (NESP)

New Medication - Micafungin 50mg Injection

posted Jul 3, 2018, 6:50 PM by Chong Ching Wern   [ updated Jul 3, 2018, 7:32 PM ]

3 July 2018 (Circular No. SP PPUM: 239/2018):
Name of Medication: Micafungin 50mg
Brand: Mycamine
Form: Injection
Manufacturer: Astellas Pharma
Formulary Category: Standard
Prescriber: Infectious Disease Specialists and Haematologists only.
Restrictions: For treatment of invasive candidiasis, prophylaxis of candida infection in patient undergoing allogenic haematopoietic stem cell transplantation.

Based on the outcome of the Drug and Therapeutics Subcommittee Meeting (Bil. 01/2017), Micafungin 50mg Injection will be replacing Caspofungin 50mg and 70mg Injection.


Micafungin 50mg Injection (Mycamine)

Medication Supply Disruption

posted Jun 12, 2018, 1:05 AM by Chong Ching Wern   [ updated Jun 12, 2018, 1:05 AM ]

12 June 2018 (Circular No. SP PPUM: 217/2018):

The following medications will be facing supply disruptions:

No.

Name of Medication

Formulary Category

Cause / Action by Pharmacy

Estimated Stock Recovery

Alternative Medication


1)

Fentanyl 100mcg/2mL Injection

Standard Formulary

· Raw material supply issues by Duopharma (M) Sdn. Bhd.

· Pharmacy Department has a balance stock of  about 1500 ampoules only.

August 2018.

Consider use of other medications which are available in our Standard Formulary

2)

Dexamethasone 8mg Injection (For IT use)



Standard Formulary

· Production ceased.

· Raw materials were found not suitable for Intrathecal preparations. 


N/A

Consider use of IT Hydrocortisone Sodium Succinate 25mg/0.5mL Injection prepared by our Manufacturing Pharmacy.

3)

Potassium Dihydrogen Phosphate 10mmol/10mL Injection

Standard Formulary

· Stock supply delivery delay by Pfizer (M) Sdn. Bhd.



Until further notice.

None, Pfizer (M) Sdn. Bhd. is the sole manufacturer of the medication.

4)

Lidocaine 1% Injection


Standard Formulary

· Stock supply issues by Pfizer (M) Sdn. Bhd.

· Remaining stocks will solely be used for cases which require intravenous administration only. 


N/A

Ward stock supplies will be switched to Lidocaine 2% Injection.

Medication Supply Disruption

posted May 29, 2018, 8:58 PM by Chong Ching Wern   [ updated Jul 3, 2018, 7:55 PM ]

28 May 2018 (Circular No. SP PPUM: 196/2018): 

The following medications will be facing supply disruptions:

No.

Name of Medication

Formulary Category

Cause / Action by Pharmacy

Estimated Stock Recovery

Alternative Medication


1)

Albumin Human 20% Injection



Standard Formulary

· Production issues by Grifols Malaysia Sdn. Bhd.

· Usage is only reserved for critical cases including 'replacement after large volume parecentesis'.


Until further notice.

None, other companies are also experiencing stock issues.

Please contact Inpatient Pharmacy first for elective surgeries. 

2)

Co-Trimoxazole 480mg Injection



Standard Formulary

· Production issues by Pfizer (M) Sdn. Bhd.

· Supply limited to patients who are unable to tolerate oral therapy. 


August 2018.

Consider use of Co-Trimoxazole 480mg Tablet in view of its oral bio-availability is comparable to the injection.

3)

Ketamine 500mg/10mL Injection

Standard Formulary

· Production issues by Duopharma (M) Sdn. Bhd. and Pharmaniaga Sdn. Bhd.



Until further notice.

Consider use of other anaesthesias which are available in our Standard Formulary.

4)

Prothrombin Complex (Factor II, VII, IX, X) Injection (Octoplex)


Standard Formulary

· Stock supply issues by Pharmaniaga Marketing Sdn. Bhd.

Early July 2018.

None.

5)

Ropivacaine 150mg/20mL Injection (Naropin)

Standard Formulary

· Stock supply issues by Aspen Malaysia Sdn. Bhd.

· Supply of medication will be controlled by Inpatient Pharmacy. 


Until further notice.

None, will notify when all stocks have been used up.

6)

Dosulepin 75mg Tablet

Standard Formulary

· Production issues by all distributors for this medication in Malaysia.


Until further notice.

Dosulepin 25mg Tablet will be used.

7)

Cisplatin 50mg/50mL Injection

Standard Formulary

· Production issues by Pfizer (M) Sdn. Bhd. and other manufacturers.

· Sorting out supplies from companies that still have leftover stocks.


Until further notice.

None, doctors are encouraged not to start new patients on this medication.

Temporary Medication - Fenofibrate 160mg Tablet

posted Apr 17, 2018, 7:18 PM by Chong Ching Wern   [ updated Apr 17, 2018, 7:33 PM ]

17 April 2018 (Circular No. SP PPUM: 134/2018):
We are pleased to inform you that Pharmaforte have taken the initiative to supply us with Apo-Fenofibrate SP 160mg Tablet as an alternative to our Apo-Fenofibrate 200mg Capsule which is currently facing supply disruptions.

Both medications are equivalent and it was agreed by our Specialists to have a direct conversion:

1 capsule of Apo-Fenofibrate 200mg =1 tablet of Apo-Fenofibrate SP 160mg

Please do note that this Apo-Fenofibrate SP 160mg will be a temporary replacement medication until the supply has resumed.
APO-Fenofibrate SP 160mg Tablets

Formulary Category Change - Lamotrigine, Levitiracetam, Topiramate

posted Apr 17, 2018, 6:33 PM by Chong Ching Wern   [ updated Apr 17, 2018, 6:39 PM ]

17 April 2018 (Circular No. SP PPUM: 132/2018):
Based on the decision of UMMC's Tender Board on 23 November 2016 (Circular No. SP PPUM: 15/2017 dated 10 January 2017), there was a change of category of the following medications from Standard Formulary to Special Formulary:
      1. Lamotrigine 50mg Tablet
      2. Lamotrigine 100mg Tablet
      3. Levetiracetam 250mg Tablet
      4. Levetiracetam 500mg Tablet
      5. Levetiracetam 1000mg Tablet
      6. Topiramate 25mg Tablet
      7. Topiramate 50mg Tablet
      8. Topiramate 100mg Tablet
However, following the agreement from our Specialists to use generic medications in treating patients, the change in formulary category from Standard Formulary to Special Formulary is cancelled.

These medications will be remained as Standard Formulary.

1-10 of 72